Related Experiment Video
Updated: Jun 23, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.1K
Optimizing GRID and Lattice Spatially Fractionated Radiation Therapy: Innovative Strategies for Radioresistant and
Mansoor M Ahmed1, Xiaodong Wu2, Majid Mohiuddin3
1Department of Radiation Oncology, Albert Einstein College of Medicine, Bronx, NY.
Seminars in Radiation Oncology
|June 16, 2024
Summary
GRID and lattice spatially fractionated radiation therapy (GRID RT and LRT) offer new ways to treat radioresistant, bulky tumors by delivering high-dose radiation in patterns that spare healthy tissue. These advanced techniques aim to improve tumor control and reduce toxicity for various cancers.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cancer Therapy
Background:
- Treating radioresistant and bulky tumors presents significant clinical challenges.
- Standard therapies often show limited efficacy against these complex tumor types.
- Novel radiation delivery methods are needed to improve outcomes.
Purpose of the Study:
- To introduce and describe GRID and lattice spatially fractionated radiation therapy (GRID RT and LRT) as advanced treatment modalities.
- To highlight the potential of GRID RT and LRT in managing radioresistant and bulky tumors.
- To discuss the application, benefits, and considerations for these techniques in various cancers.
Main Methods:
- GRID RT delivers radiation in a 2D pattern of high-dose peaks (15-20 Gy).
- LRT utilizes a 3D array of high-dose vertices (10-20 Gy) spaced 2-5 cm apart.
- Treatment patterns require careful tailoring to maximize dose escalation while sparing organs at risk.
Main Results:
- Both GRID RT and LRT create high-dose peaks and low-dose valleys, enabling significant tumor destruction while sparing healthy tissue.
- These techniques show promise for various cancers, including sarcomas, renal cell carcinoma, GISTs, pancreatic cancer, glioblastoma, and hepatocellular carcinoma.
- A phased approach combining high-dose induction therapy with standard fractionated therapy can maximize immune modulation and tumor control.
Conclusions:
- GRID RT and LRT offer a promising framework for treating radioresistant and bulky tumors, potentially improving tumor control and reducing toxicity.
- Careful planning, including precise dosimetry and patient selection, is crucial for optimal outcomes.
- Further clinical trials and standardized guidelines are needed to refine these innovative cancer treatment strategies.
Related Concept Videos
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

